Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection
- 23 February 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 772 (2) , 219-228
- https://doi.org/10.1016/s1570-0232(02)00088-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2000
- Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasmaJournal of the American Society for Mass Spectrometry, 1999
- Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatinBritish Journal of Clinical Pharmacology, 1998
- Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*Clinical Pharmacology & Therapeutics, 1998
- Development, Validation, and Interlaboratory Comparison of an HMG-CoA Reductase Inhibition Assay for Quantitation of Atorvastatin in Plasma MatricesTherapeutic Drug Monitoring, 1998
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Enzyme-Linked Immunosorbent Assay of Pravastatin, a MG-CoA Reductase Inhibitor, in Human PlasmaJournal of Immunoassay, 1996
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometryJournal of Mass Spectrometry, 1989